Science Explorer Back to mapMap
Discussion
Institution · BARMER GEK

Most cited papers from BARMER GEK

BARMER GEK

What are the most cited papers from BARMER GEK?

The most cited paper from BARMER GEK is "Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis" (Eva Freisinger, Jeanette Koeppe, Joachim Gerß et al., 2019), with 194 citations. Next come "Instruments to measure outcomes of post-intensive care syndrome in outpatient care settings – Results of an expert consensus and feasibility field test" (146) and "German Diabetes Management Programs Improve Quality Of Care And Curb Costs" (129).

Showing 50 of 60 papers. Every paper with more than 24 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis Eva Freisinger, Jeanette Koeppe, Joachim Gerß et al. · European Heart Journal Open access 12 Sep 2019 194
2 Instruments to measure outcomes of post-intensive care syndrome in outpatient care settings – Results of an expert consensus and feasibility field test Claudia Spies, Henning Krampe, Nicolas Paul et al. · Journal of the Intensive Care Society Open access 14 May 2020 146
3 German Diabetes Management Programs Improve Quality Of Care And Curb Costs Stephanie Stock, Anna Drabik-Chamerska, Guido Büscher et al. · Health Affairs Dec 2010 129
4 Editor's Choice – Long Term Survival after Femoropopliteal Artery Revascularisation with Paclitaxel Coated Devices: A Propensity Score Matched Cohort Analysis Christian‐Alexander Behrendt, Art Sedrakyan, Frederik Peters et al. · European Journal of Vascular and Endovascular Surgery Open access 8 Jan 2020 121
5 Multivariate analysis of independent determinants of ADL/IADL and quality of life in the elderly Sebastian Beltz, Simone Gloystein, Thomas Litschko et al. · BMC Geriatrics Open access 23 Nov 2022 114
6 Editor's Choice – Comorbidity Patterns Among Patients with Peripheral Arterial Occlusive Disease in Germany: A Trend Analysis of Health Insurance Claims Data Thea Kreutzburg, Frederik Peters, Henrik Christian Rieß et al. · European Journal of Vascular and Endovascular Surgery Open access 16 Nov 2019 101
7 Long‐term opioid therapy for chronic non‐cancer pain in Germany Ursula Marschall, Helmut L’Hoest, Lukas Radbruch et al. · European Journal of Pain 22 Oct 2015 98
8 A randomized, double‐blind, phase III , multicentre study to evaluate the safety and efficacy of BF ‐200 ALA (Ameluz ® ) vs. placebo in the field‐directed treatment of mild‐to‐moderate actinic keratosis with photodynamic therapy (PDT) when using the BF ‐Rhodo LED ® lamp Uwe Reinhold, Thomas Dirschka, Rolf Ostendorf et al. · British Journal of Dermatology Open access 27 Feb 2016 94
9 Palliativversorgung am Lebensende in Deutschland die SAVOIR-Studiengruppe, Bianka Ditscheid, Markus H. Krause et al. · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz Open access 13 Nov 2020 90
10 Tuberculosis: cost of illness in Germany Roland Diel, Stefan Rutz, Stefanie Castell et al. · European Respiratory Journal 20 Jan 2012 90
11 Digital Treatment of Back Pain versus Standard of Care: The Cluster-Randomized Controlled Trial, Rise-uP Janosch A. Priebe, Katharina K. Haas, Leida F Moreno Sanchez et al. · Journal of Pain Research Open access Jul 2020 80
12 Lower-extremity amputations in people with and without diabetes in Germany, 2008–2012 – an analysis of more than 30 million inhabitants Heiner Claessen, Maria Narres, Burkhard Haastert et al. · Clinical Epidemiology Open access Apr 2018 80
13 Lack of specialist care is associated with increased morbidity and mortality in adult congenital heart disease: a population-based study Gerhard‐Paul Diller, Stefan Orwat, Astrid Elisabeth Lammers et al. · European Heart Journal 24 Jun 2021 75
14 Temporal trends in the presentation of cardiovascular and cerebrovascular emergencies during the COVID-19 pandemic in Germany: an analysis of health insurance claims Moritz Seiffert, Fabian J. Brunner, Marko Remmel et al. · Clinical Research in Cardiology Open access 4 Aug 2020 74
15 Maternal and neonatal complications in women with congenital heart disease: a nationwide analysis Astrid Elisabeth Lammers, Gerhard‐Paul Diller, Rieke Lober et al. · European Heart Journal 8 Sep 2021 71
16 Editor's Choice – The GermanVasc Score: A Pragmatic Risk Score Predicts Five Year Amputation Free Survival in Patients with Peripheral Arterial Occlusive Disease Thea Kreutzburg, Frederik Peters, Jenny Kuchenbecker et al. · European Journal of Vascular and Endovascular Surgery Open access 16 Dec 2020 71
17 Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44 000 patients Eva Freisinger, Joachim Gerß, Lena Makowski et al. · European Heart Journal 26 Sep 2020 71
18 Deutsche Empfehlungen zur gesundheitsökonomischen Evaluation Kurt P Bestehorn et al. · Medizinische Klinik - Intensivmedizin und Notfallmedizin 2000 63
19 Impact of the COVID-19 pandemic on appendicitis treatment in Germany—a population-based analysis Franziska Köhler, Laura Acar, Anne van den Berg et al. · Langenbeck s Archives of Surgery Open access 9 Jan 2021 59
20 Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts Niels B. Peek et al. · European Heart Journal Open access 8 Oct 2024 58
21 The OAC3-PAD Risk Score Predicts Major Bleeding Events one Year after Hospitalisation for Peripheral Artery Disease Christian‐Alexander Behrendt, Thea Kreutzburg, Joakim Nordanstig et al. · European Journal of Vascular and Endovascular Surgery Open access 3 Feb 2022 58
22 Editor's Choice – Optimal Pharmacological Treatment of Symptomatic Peripheral Arterial Occlusive Disease and Evidence of Female Patient Disadvantage: An Analysis of Health Insurance Claims Data Frederik Peters, Thea Kreutzburg, Henrik Christian Rieß et al. · European Journal of Vascular and Endovascular Surgery Open access 12 Jul 2020 57
23 Survival of patients undergoing cardiac resynchronization therapy with or without defibrillator: the RESET-CRT project Moritz Hadwiger, Nikolaos Dagres, Janina Haug et al. · European Heart Journal Open access 31 Jan 2022 52
24 Tabakentwöhnung bei COPD - S3 Leitlinie herausgegeben von der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin Stefan Andreas, Akshee Batra, Jürgen Behr et al. · Pneumologie May 2008 51
25 Effectiveness of the application of an electronic medication management support system in patients with polypharmacy in general practice: a study protocol of cluster-randomised controlled trial (AdAM) Beate Sigrid Müller et al. · BMJ Open Open access Sep 2021 46
26 Behandlung und Krankheitskosten des Fibromyalgiesyndroms in Deutschland Ursula Marschall, B. Arnold, Winfried Häuser · Der Schmerz Aug 2011 46
27 Tabakentwöhnung bei COPD Stefan Andreas, Anil Krishnaram Batra, Jürgen Behr et al. · Pneumologie Open access 25 Feb 2014 45
28 Chronic Care Model Strategies In The United States And Germany Deliver Patient-Centered, High-Quality Diabetes Care Stephanie Stock, James M. Pitcavage, Dušan Simić et al. · Health Affairs Sep 2014 44
29 The prevalence and impact of comorbidities on patients with axial spondyloarthritis: results from a nationwide population-based study Imke Redeker, Johanna Callhoff, Falk Hoffmann et al. · Arthritis Research & Therapy Open access 10 Sep 2020 43
30 Inanspruchnahme von Palliativversorgung am Lebensende in Deutschland: zeitlicher Verlauf (2016–2019) und regionale Variabilität Bianka Ditscheid, Franziska Meißner, Cordula Gebel et al. · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz Open access 10 Mar 2023 42
31 Effectiveness of two types of palliative home care in cancer and non-cancer patients: A retrospective population-based study using claims data Markus H. Krause, Bianka Ditscheid, Thomas Lehmann et al. · Palliative Medicine Open access Jun 2021 40
32 Financial incentives in the German Statutory Health Insurance: New findings, new questions Stephanie Stock, Harald Schmidt, Guido Büscher et al. · Health Policy 28 Jan 2010 40
33 Indicators of outcome quality in peripheral arterial disease revascularisations – a Delphi expert consensus Henrik Christian Rieß, E. Sebastian Debus, Thea Schwaneberg et al. · VASA Open access Jun 2018 39
34 Evaluation of the IRF-2 Gene as a Candidate for PSORS3 John Foerster, Ilja Maria Nolte, Susann Schweiger et al. · Journal of Investigative Dermatology Open access 2004 39
35 Long‐Term Effectiveness and Safety of Initiating Statin Therapy After Index Revascularization In Patients With Peripheral Arterial Occlusive Disease Frederik Peters, Jenny Kuchenbecker, Thea Kreutzburg et al. · Journal of the American Heart Association Open access 13 Nov 2020 38
36 The impact of extra-musculoskeletal manifestations on disease activity, functional status, and treatment patterns in patients with axial spondyloarthritis: results from a nationwide population-based study Imke Redeker, Britta Siegmund, Kamran Ghoreschi et al. · Therapeutic Advances in Musculoskeletal Disease Open access 2020 37
37 Long Term Outcomes After Revascularisations Below the Knee with Paclitaxel Coated Devices: A Propensity Score Matched Cohort Analysis Franziska Heidemann, Frederik Peters, Jenny Kuchenbecker et al. · European Journal of Vascular and Endovascular Surgery Open access 14 Aug 2020 37
38 Pediatric Chronic Inflammatory Bowel Disease in a German Statutory Health INSURANCE—Incidence Rates From 2009 to 2012 Regina Wittig, Lucia Albers, Sibylle Koletzko et al. · Journal of Pediatric Gastroenterology and Nutrition 4 Oct 2018 37
39 Haplotype Sharing Analysis Identifies a Retroviral dUTPase as Candidate Susceptibility Gene for Psoriasis John Foerster, Ilja Maria Nolte, Judith Junge et al. · Journal of Investigative Dermatology Open access 2005 37
40 A health insurance claims analysis on the effect of female sex on long-term outcomes after peripheral endovascular interventions for symptomatic peripheral arterial occlusive disease Franziska Heidemann, Jenny Kuchenbecker, Frederik Peters et al. · Journal of Vascular Surgery Open access 27 Feb 2021 35
41 Initiation of SGLT2 Inhibitors and the Risk of Lower Extremity Minor and Major Amputation in Patients with Type 2 Diabetes and Peripheral Arterial Disease: A Health Claims Data Analysis Roman Nikolaevich Rodionov, Frederik Peters, Ursula Marschall et al. · European Journal of Vascular and Endovascular Surgery Open access 12 Nov 2021 34
42 Was bewegt die Nicht-Beweger? Alfred Rütten, Karim Abu‐Omar, Rüdiger Meierjürgen et al. · Prävention und Gesundheitsförderung 16 Jun 2009 32
43 Cost-effectiveness of noninvasive telemedical interventional management in patients with heart failure: health economic analysis of the TIM-HF2 trial Hanna Sydow, Sandra Prescher, Friedrich Koehler et al. · Clinical Research in Cardiology Open access 11 Dec 2021 31
44 Enhanced Recovery after Intensive Care (ERIC): study protocol for a German stepped wedge cluster randomised controlled trial to evaluate the effectiveness of a critical care telehealth program on process quality and functional outcomes Christine Adrion, Björn Weiß, Nicolas Paul et al. · BMJ Open Open access Sep 2020 31
45 Major depression treatment in Germany–descriptive analysis of health insurance fund routine data and assessment of guideline-adherence Hauke Felix Wiegand, Christoph Sievers, Matthias Schillinger et al. · Journal of Affective Disorders 8 Oct 2015 31
46 The Prevalence, Comorbidity, Management and Costs of Irritable Bowel Syndrome: An Observational Study Using Routine Health Insurance Data Winfried Häuser, Ursula Marschall, Peter Layer et al. · Deutsches Ärzteblatt international Open access 27 Jun 2019 30
47 Administrative Prävalenz, Behandlung und Krankheitskosten der somatoformen Schmerzstörung Winfried Häuser, Ursula Marschall, Helmut L’Hoest et al. · Der Schmerz 16 Jul 2013 30
48 Evaluation eines frühen interdisziplinären multimodalen Assessments für Patienten mit Schmerzen Ulrike Kaiser et al. · Der Schmerz Open access 17 Sep 2020 29
49 Long-term incidence of cancer after index treatment for symptomatic peripheral arterial disease – a health insurance claims data analysis Mark Kaschwich, Frederik Peters, Sandra Hischke et al. · VASA Open access 18 Aug 2020 28
50 Preliminary analysis of short term financial implications of a prevention bonus program: First results from the German statutory health insurance Stephanie Stock, Björn Stollenwerk, Gabriele Klever-Deichert et al. · Sozial- und Präventivmedizin Apr 2008 28

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.